U.S. Hospitality Stock News

NYSEAM:GPUS
NYSEAM:GPUSIndustrials

Assessing Hyperscale Data (GPUS) Valuation After Bitcoin Treasury Grows Beyond Market Capitalization

Hyperscale Data (GPUS) is back in focus after releasing preliminary year end asset estimates, detailing a Bitcoin treasury that now exceeds its market capitalization and pledging more frequent balance sheet updates through 2026. See our latest analysis for Hyperscale Data. The latest balance sheet update and Bitcoin focus come after a volatile period, with a 93.68% 7 day share price return and a 30.26% year to date share price return, set against a 1 year total shareholder return of...
NasdaqGM:IMRX
NasdaqGM:IMRXBiotechs

Assessing Immuneering (IMRX) Valuation After Positive Phase 2a Pancreatic Cancer Trial Progress

Immuneering (IMRX) is back on traders’ screens after releasing updated Phase 2a data for atebimetinib plus modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer, showing higher overall survival and response metrics than standard benchmarks. See our latest analysis for Immuneering. The updated atebimetinib data arrive after a tough recent stretch, with the share price at US$4.73 and a 1 day share price return of 43.22% decline. However, a 1 year total shareholder return of 136.5%...
NYSE:CMA
NYSE:CMABanks

Is Comerica (CMA) Getting Ahead Of Itself After A 55% One Year Share Price Jump

If you are wondering whether Comerica's share price still offers value after a strong run, this review will help you separate sentiment from what the numbers suggest. Comerica's stock last closed at US$92.56, with returns of 6.5% over 7 days, 10.5% over 30 days, 4.4% year to date, 55.1% over 1 year, 57.3% over 3 years and 76.8% over 5 years. Recent market attention on U.S. regional banks has kept Comerica in focus, as investors reassess how interest rate expectations and credit conditions...
NasdaqGM:CVAC
NasdaqGM:CVACBiotechs

Does CureVac’s (CVAC) NASDAQ Exit Quietly Recast Its Risk Profile and Equity Story?

CureVac N.V. recently closed its August 14, 2020 shelf registration in the amount of €3.21 million, covering 26,768,980 common shares for an ESOP-related offering. A day earlier, CureVac was removed from the NASDAQ Composite Index, a change that can influence trading behavior as index-tracking investors rebalance their holdings. We will now examine how CureVac’s removal from the NASDAQ Composite Index may influence its pre-existing investment narrative and risk profile. Uncover the next big...
NYSE:REZI
NYSE:REZIBuilding

Is It Too Late To Consider Resideo Technologies (REZI) After A 63% One-Year Rally?

If you are wondering whether Resideo Technologies is priced attractively or already baking in high expectations, you are in the right place. The stock last closed at US$36.86, with returns of 5.0% over 7 days, 9.8% over 30 days, 4.8% year to date, 63.4% over 1 year, 98.2% over 3 years, and 44.5% over 5 years, which raises fair questions about how much value is now reflected in the share price. Recent coverage has focused on Resideo's position in residential comfort, security and energy...
NYSE:CADE
NYSE:CADEBanks

Is Cadence Bank (CADE) Price Fair After Strong Multi‑Year Share Performance?

If you are wondering whether Cadence Bank's current share price offers good value or not, you are in the right place because this article focuses squarely on what investors may be paying for today. Cadence Bank's stock has recently closed at US$45.67, with returns of 6.6% over 7 days, 9.7% over 30 days, 5.7% year to date, 34.3% over 1 year and 76.9% over 5 years. This raises questions about how much of this performance is already reflected in the price. Recent attention on Cadence Bank has...
NYSE:HOUS
NYSE:HOUSReal Estate

A Look At Anywhere Real Estate (HOUS) Valuation After Recent Share Price Surge

Anywhere Real Estate: Recent Performance Snapshot Anywhere Real Estate (HOUS) has been catching investor attention after a sharp move in its share price, with recent returns standing at 3.6% over the past day and 24.6% across the past week. Those short term gains sit alongside a month return of 20% and an approximately 87% move over the past 3 months, putting the current share price at US$17.64 as of the latest close. See our latest analysis for Anywhere Real Estate. Looking beyond the recent...
NasdaqCM:TOI
NasdaqCM:TOIHealthcare

Assessing Oncology Institute (TOI) Valuation After Mark Stolper Joins The Board

Oncology Institute (TOI) recently drew fresh investor attention after announcing that Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, joined its Board of Directors, bringing additional healthcare and public markets experience. See our latest analysis for Oncology Institute. The board appointment comes as Oncology Institute’s share price has gained momentum, with a 21.1% 7 day share price return and a strong 1 year total shareholder return, although the 5 year...